The positive feedback loop between Nrf2 and phosphogluconate dehydrogenase stimulates proliferation and clonogenicity

Athena Jessica Ong1, Soma Saeidi1,2, Ngo Hoang Kieu Chi1

  • 1Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.

Free Radical Research
|April 28, 2020
PubMed

Insights

Nuclear factor-erythroid-2-related factor 2 (Nrf2) drives cancer growth by increasing phosphogluconate dehydrogenase (PGD). This study reveals a positive feedback loop between Nrf2 and PGD in hepatoma cells, crucial for their proliferation and survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Nuclear factor-erythroid-2-related factor 2 (Nrf2) is implicated in cancer progression via metabolic reprogramming.
  • The precise molecular mechanisms of Nrf2's oncogenic functions remain unclear.
  • Pentose phosphate pathway (PPP) enzymes are increasingly recognized for their role in cancer progression.

Purpose of the Study:

  • To investigate the role of phosphogluconate dehydrogenase (PGD), a PPP enzyme, in the proliferation and migration of human hepatoma HepG2 cells.
  • To elucidate the regulatory relationship between Nrf2 and PGD in hepatoma cells.

Main Methods:

  • Genetic manipulation of Nrf2 and PGD expression in HepG2 cells (gene ablation, overexpression, knockdown).
  • Analysis of gene and protein expression levels.
  • Assessment of cell proliferation, survival, migration, and clonogenicity.
  • Reporter assays to confirm transcriptional regulation via antioxidant response element (ARE).

Main Results:

  • Nrf2 genetic ablation reduced PGD expression at transcriptional and translational levels.
  • Nrf2 directly binds to the ARE in the PGD promoter, regulating its transcription.
  • Nrf2 overexpression enhanced HepG2 cell proliferation, survival, and migration, effects reversed by PGD silencing.
  • PGD knockdown inhibited HepG2 cell proliferation and clonogenicity and downregulated Nrf2 expression.
  • A positive feedback loop between Nrf2 and PGD was identified, promoting hepatoma cell growth.
  • Ribulose-5-phosphate treatment upregulated Nrf2 in a concentration-dependent manner.

Conclusions:

  • Nrf2 promotes hepatoma cell growth and progression, partly by inducing PGD transcription.
  • A positive feedback loop exists between Nrf2 and PGD, essential for hepatoma cell proliferation and survival.
  • Targeting the Nrf2-PGD axis may offer therapeutic strategies for hepatoma treatment.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Cell Signaling Feedback Loops01:07

Cell Signaling Feedback Loops

Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
7.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K